Kailera Therapeutics, Inc. Common Stock (NASDAQ: KLRA) last traded at $10.85, up 0.74% on the session. The quote above updates while this page is open; the figures below are drawn from Kailera Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kailera Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker KLRA. Its market capitalisation is $1.41 billion.
Valuation measures for Kailera Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.41B |
|---|---|
| Enterprise value | $1.37B |
| Price / book | 1.26 |
| Beta | 1.03 |
Trailing-twelve-month figures tagged in Kailera Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Cash |
|---|
| $130.30M |
Range and volume for KLRA over the past 52 weeks.
| 52-week high | $28.23 |
|---|---|
| 52-week low | $9.76 |
| Volume | 681.0K |
| Average volume | 897.1K |
| Previous close | $10.77 |
Invest a chosen dollar amount in Kailera Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KLRA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.